LHFPL3 and melanoma: Collectively, these findings demonstrated that LHFPL3-AS1-long directly interacted with miR-181 to inhibit the mRNA degradation of Bcl-2 (the target of miR-181), thus suppressing apoptosis of melanoma stem cells.